Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif.--(BUSINESS WIRE)--Jan 9, 2020--
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 38 th Annual J.P. Morgan Healthcare Conference on Thursday, January 16 th at 8:30 a.m. PT in San Francisco.
The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200109005263/en/
CONTACT: Investor Relations – Global
email@example.com Media Inquiries – Global
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH GENETICS CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Sangamo Therapeutics, Inc.
Copyright Business Wire 2020.
PUB: 01/09/2020 08:30 AM/DISC: 01/09/2020 08:30 AM